-
US Justice Dept releasing new batch of Epstein files
-
South Africa and Israel expel envoys in deepening feud
-
French eyewear maker in spotlight after presidential showing
-
Olympic dream 'not over', Vonn says after crash
-
Brazil's Lula discharged after cataract surgery
-
US Senate races to limit shutdown fallout as Trump-backed deal stalls
-
'He probably would've survived': Iran targeting hospitals in crackdown
-
Djokovic stuns Sinner to set up Australian Open final with Alcaraz
-
Mateta omitted from Palace squad to face Forest
-
Gold, silver prices tumble as investors soothed by Trump's Fed pick
-
Trump attorney general orders arrest of ex-CNN anchor covering protests
-
Djokovic 'pushed to the limit' in stunning late-night Sinner upset
-
Tunisia's famed blue-and-white village threatened after record rains
-
Top EU official voices 'shock' at Minneapolis violence
-
Kremlin says agreed to halt strikes on Kyiv until Sunday
-
Carrick calls for calm after flying start to Man Utd reign
-
Djokovic to meet Alcaraz in Melbourne final after five-set marathon
-
Italian officials to testify in trial over deadly migrant shipwreck
-
Iran says defence capabilities 'never' up for negotiation
-
UN appeals for more support for flood-hit Mozambicans
-
Lijnders urges Man City to pile pressure on Arsenal in title race
-
Fulham sign Man City winger Oscar Bobb
-
Strasbourg's Argentine striker Panichelli sets sights on PSG, World Cup
-
Jesus 'made love': Colombian president irks Christians with steamy claim
-
IAEA board meets over Ukraine nuclear safety concerns
-
Eurozone growth beats 2025 forecasts despite Trump woes
-
Israel to partially reopen Gaza's Rafah crossing on Sunday
-
Dutch PM-elect Jetten says not yet time to talk to Putin
-
Social media fuels surge in UK men seeking testosterone jabs
-
Forest face Fenerbahce, Celtic draw Stuttgart in Europa League play-offs
-
US speed queen Vonn crashes at Crans-Montana, one week before Olympics
-
Trump nominates former US Fed official as next central bank chief
-
Alcaraz defends controversial timeout after beaten Zverev fumes
-
New Dutch government pledges ongoing Ukraine support
-
Newcastle still coping with fallout from Isak exit, says Howe
-
Chad, France eye economic cooperation as they reset strained ties
-
Real Madrid to play Benfica, PSG face Monaco in Champions League play-offs
-
Everton winger Grealish set to miss rest of season in World Cup blow
-
Trump brands Minneapolis nurse killed by federal agents an 'agitator'
-
Arteta focuses on the positives despite Arsenal stumble
-
Fijian Drua sign France international back Vakatawa
-
Kevin Warsh, a former Fed 'hawk' now in tune with Trump
-
Zverev rails at Alcaraz timeout in 'one of the best battles ever'
-
Turkey leads Iran diplomatic push as Trump softens strike threat
-
Zelensky backs energy ceasefire, Russia bombs Ukraine despite Trump intervention
-
'Superman' Li Ka-shing, Hong Kong billionaire behind Panama ports deal
-
Skiing great Lindsey Vonn crashes at Crans-Montana, one week before Olympics
-
Slot warns Liverpool 'can't afford mistakes' in top-four scrap
-
Paris show by late Martin Parr views his photos through political lens
-
'Believing' Alcaraz outlasts Zverev in epic to reach maiden Melbourne final
| RBGPF | 1.65% | 83.78 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| RYCEF | -2.69% | 16 | $ | |
| NGG | -0.33% | 84.77 | $ | |
| CMSC | -0.02% | 23.69 | $ | |
| AZN | 0.38% | 92.94 | $ | |
| GSK | 1.03% | 51.18 | $ | |
| BP | 0.09% | 38.075 | $ | |
| BTI | -0.47% | 59.93 | $ | |
| RIO | -3.08% | 92.29 | $ | |
| VOD | -0.55% | 14.63 | $ | |
| BCE | 0.1% | 25.51 | $ | |
| JRI | 0.23% | 12.985 | $ | |
| BCC | -1.31% | 79.132 | $ | |
| RELX | -1.25% | 35.72 | $ | |
| CMSD | 0.05% | 24.073 | $ |
RFK Jr vaccine panel targets childhood vaccinations in first meeting
A medical panel appointed by US Health Secretary Robert F. Kennedy Jr. held its first meeting Wednesday, pledging to revisit the childhood vaccine schedule and promoting themes long embraced by anti-vaccine activists.
The Advisory Committee on Immunization Practices (ACIP), an independent group that reviews scientific evidence to determine who should receive vaccines and when, rarely draws headlines.
But that changed after Kennedy -- who spent decades spreading vaccine misinformation before becoming President Donald Trump's top health official -- abruptly fired all 17 sitting members earlier this month, accusing them of industry conflicts of interest.
He replaced them with eight new appointees, including scientist Robert Malone, known for promoting false claims during the Covid-19 pandemic.
The panel's new chair, Martin Kulldorff, co-authored the Great Barrington Declaration, which called for ending lockdowns in October 2020, even though it was known Covid vaccines were nearing approval.
Kulldorff opened the meeting by announcing a new working group to re-examine the childhood vaccine schedule. He raised questions about the potential cumulative effects of vaccine interactions and the wisdom of administering the Hepatitis B shot "on the day of birth."
Experts met the announcement with skepticism.
"The rationale for Hepatitis B vaccination prior to hospital discharge (not 'day of birth') for neonates is well documented and established -- but it's another pet cause of the anti-vaccine movement," Amesh Adalja, an infectious disease expert at Johns Hopkins University, told AFP.
The panel's first major test comes Thursday, when it votes on whether to recommend a newly approved antibody shot against RSV, or respiratory syncytial virus, for infants whose mothers did not receive an RSV vaccine during pregnancy.
- Fabricated citation -
The meeting agenda also signaled plans to revisit long-settled debates around thimerosal, a mercury-based preservative, and to highlight rare side effects linked to measles shots -- with no planned discussion of the overwhelming public health benefits of immunization.
Lyn Redwood, a nurse and former leader of Children's Health Defense -- the anti-vaccine group once chaired by Kennedy -- is scheduled to present Thursday on thimerosal.
Scientists reviewing her slides, posted ahead of the meeting, discovered she cited a 2008 paper by RF Berman titled "Low-level neonatal thimerosal exposure: Long-term consequences in the brain."
No such study exists. While Berman did publish a paper that year, it appeared in a different journal and found no link between thimerosal and autism.
The presentation was quietly revised without explanation. The incident echoed possible AI chatbot hallucinations blamed for similar sourcing errors in Kennedy's recent flagship Make America Healthy Again report.
The Centers for Disease Control and Prevention (CDC), which is overseeing the meeting, had been set to deliver a presentation defending thimerosal, but that document was deleted from the website at the last minute.
The panel will vote on thimerosal-containing flu vaccines on Thursday afternoon.
- Sweeping implications -
During a discussion on Covid-19 vaccines, Malone suggested that mRNA shots may have triggered novel, poorly understood effects on the immune system.
CDC scientist Sarah Meyer pushed back, saying the nation's vaccine safety systems would have flagged such issues if they had occurred.
The panel will also revive a debate on the combined measles, mumps, rubella, and varicella (MMRV) shot, which is offered as an alternative to separate MMR and varicella injections.
While the combined version spares children an extra jab, it slightly increases the risk of febrile seizures -- a rare and typically harmless side effect.
Current guidelines already recommend splitting the doses for a child's first shot at 12–47 months, leaving experts puzzled as to why the issue is being re-litigated.
As panelists scrutinize rare side effects, there is no plan to discuss the measles vaccine's enormous public health benefits -- including preventing millions of hospitalizations.
The United States, which declared measles eliminated in 2000, is experiencing its worst outbreak in decades -- with over 1,200 cases and three confirmed deaths this year.
ACIP's recommendations could carry sweeping implications, shaping school entry requirements and insurance coverage across the country.
A.Ruiz--AT